Acute otitis media and sinusitis treatment durations should be shortened: Pro

Sunday, April 24, 2022

1:00 PM – 1:10 PM US MT

Location: Convention Center: Mile High Ballroom 1EF

Speaker(s)

Ana Vaughan, MD, MPH
Associate Hospital Epidemiologist
Boston Children's Hospital, United States

Participants should be aware of the following financial/non-financial relationships:

Ana Vaughan, MD, MPH: ● Arcturus Therapeutics (Ended In the Past 24 Months) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Asana Inc (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Bionano Genomics Inc (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Butterfly Network Inc (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● CareDX (Ended In the Past 24 Months) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● CRISPR Therapeutics (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Editas Medicine Inc (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Exact Sciences Corp (Ended In the Past 24 Months) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Fate Therapeutics Inc (Ended In the Past 24 Months) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Genetic Technologies (Ended In the Past 24 Months) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● GoodRX (Ended In the Past 24 Months) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Illumina Inc (Ended In the Past 24 Months) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Intellia Therapeutics Inc (Ended In the Past 24 Months) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Invitae Corp (Ended In the Past 24 Months) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Iovance Biotherapeutics Inc (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Pacific Biosciences of California, Inc (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Personalis Inc (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Proto Labs Inc (Ended In the Past 24 Months) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Teledoc Health Inc (Ended In the Past 24 Months) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Twist Bioscience Corp (Ended In the Past 24 Months) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).